Role of Oct4 in maintaining and regaining stem cell pluripotency

Guilai Shi; Ying Jin
May 2010
Stem Cell Research & Therapy;2010, Vol. 1 Issue 5, p1
Academic Journal
Pluripotency, a characteristic of cells in the inner cell mass of the mammalian preimplantation blastocyst as well as of embryonic stem cells, is defined as the ability of a cell to generate all of the cell types of an organism. A group of transcription factors is essential for the establishment and maintenance of the pluripotent state. Recent studies have demonstrated that differentiated somatic cells could be reverted to a pluripotent state by the overexpression of a set of transcription factors, further highlighting the significance of transcription factors in the control of pluripotency. Among these factors, a member of the POU transcription factor family, Oct4, is central to the machinery governing pluripotency. Oct4 is highly expressed in pluripotent cells and becomes silenced upon differentiation. Interestingly, the precise expression level of Oct4 determines the fate of embryonic stem cells. Therefore, to control the expression of Oct4 precisely, a variety of regulators function at multiple levels, including transcription, translation of mRNA and post-translational modification. Additionally, in cooperation with Sox2, Nanog and other members of the core transcriptional regulatory circuitry, Oct4 activates both protein-coding genes and noncoding RNAs necessary for pluripotency. Simultaneously, in association with transcriptional repressive complexes, Oct4 represses another set of targets involved in developmental processes. Importantly, Oct4 can re-establish pluripotency in somatic cells, and proper reprogramming of Oct4 expression is indispensable for deriving genuine induced pluripotent stem cell lines. In the past several years, genome-wide identification of Oct4 target genes and Oct4-centered protein interactomes has been reported, indicating that Oct4 exerts tight control over pluripotency regulator expression and protects embryonic stem cells in an undifferentiated state. Nevertheless, further investigation is required to fully elucidate the underlying molecular mechanisms through which Oct4 maintains and reinitiates pluripotency. Systemic and dynamic exploration of the protein complexes and target genes associated with Oct4 will help to elucidate the role of Oct4 more comprehensively.


Related Articles

  • A defined Oct4 level governs cell state transitions of pluripotency entry and differentiation into all embryonic lineages. Radzisheuskaya, Aliaksandra; Le Bin Chia, Gloryn; dos Santos, Rodrigo L.; Theunissen, Thorold W.; Castro, L. Filipe C.; Nichols, Jennifer; Silva, José C. R. // Nature Cell Biology;Jun2013, Vol. 15 Issue 6, p579 

    Oct4 is considered a master transcription factor for pluripotent cell self-renewal, but its biology remains poorly understood. Here, we investigated the role of Oct4 using the process of induced pluripotency. We found that a defined embryonic stem cell (ESC) level of Oct4 is required for...

  • The dosage of Patz1 modulates reprogramming process. Hui Ma; Jin Rong Ow; Bobby Cheng Peow Tan; Ziyi Goh; Bo Feng; Yuin Han Loh; Fedele, Monica; Hu Li; Qiang Wu // Scientific Reports;12/19/2014, p1 

    The acquisition of pluripotent cells can be achieved by combined overexpression of transcription factors Oct4, Klf4, Sox2 and c-Myc in somatic cells. This cellular reprogramming process overcomes various barriers to re-activate pluripotency genes and re-acquire the highly dynamic pluripotent...

  • Auxetic nuclei in embryonic stem cells exiting pluripotency. Pagliara, Stefano; Franze, Kristian; McClain, Crystal R.; Wylde, George W.; Fisher, Cynthia L.; Franklin, Robin J. M.; Kabla, Alexandre J.; Keyser, Ulrich F.; Chalut, Kevin J. // Nature Materials;Jun2014, Vol. 13 Issue 6, p638 

    Embryonic stem cells (ESCs) self-renew in a state of naïve pluripotency in which they are competent to generate all somatic cells. It has been hypothesized that, before irreversibly committing, ESCs pass through at least one metastable transition state. This transition would represent a...

  • Reprogramming to Pluripotency through a Somatic Stem Cell Intermediate. Marthaler, Adele G.; Tiemann, Ulf; Araúzo-Bravo, Marcos J.; Wu, Guangming; Zaehres, Holm; Hyun, Jung Keun; Han, Dong Wook; Schöler, Hans R.; Tapia, Natalia // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Transcription factor-based reprogramming can lead to the successful switching of cell fates. We have recently reported that mouse embryonic fibroblasts (MEFs) can be directly reprogrammed into induced neural stem cells (iNSCs) after the forced expression of Brn4, Sox2, Klf4, and Myc. Here, we...

  • Advances in MicroRNA-Mediated Reprogramming Technology. Chih-Hao Kuo; Shao-Yao Ying // Stem Cells International;2012, p1 

    The use of somatic cells to generate induced-pluripotent stem cells (iPSCs), which have gene characteristic resembling those of human embryonic stem cells (hESCs), has opened up a new avenue to produce patient-specific stem cells for regenerative medicine. MicroRNAs (miRNAs) have gained much...

  • Ethical Issues in Embryonic Stem Cell Research and Possible Solutions using Induced Pluripotent Stem Cells: Ethical Comparison of Embryonic Stem (ES) Cells and Induced Pluripotent Stem (iPS) Cells. Takagi, Miyako // International Journal of the Humanities;2010, Vol. 8 Issue 6, p65 

    Human ES cells that can develop into many different cell types of the body are isolated from few-days-old human embryos. Some researchers believe that the destruction of an embryo is equivalent to destroying a human life. They object to the destruction of human embryos for identifying medical...

  • Drug Discovery Models and Toxicity Testing Using Embryonic and Induced Pluripotent Stem-Cell-Derived Cardiac and Neuronal Cells. Deshmukh, Rahul S.; Kovács, Krisztián A; Dinnyés, András // Stem Cells International;2012, p1 

    Development of induced pluripotent stemcells (iPSCs) using forced expression of specific sets of transcription factors has changed the field of stem cell research extensively. Two important limitations for research application of embryonic stem cells (ESCs), namely, ethical and immunological...

  • Stem cells: Abnormalities during reprogramming.  // Nature Methods;Sep2014, Vol. 11 Issue 9, p891 

    The article discusses research which compared human somatic cell nuclear transfer-embryonic stem (SCNT-ES) cells and induced pluripotent stem cells (iPSC) generated using the same source of dermal fibroblasts as donor cells.

  • An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs. Menon, Siddharth; Shailendra, Siny; Renda, Andrea; Longaker, Michael; Quarto, Natalina // International Journal of Molecular Sciences;2016, Vol. 17 Issue 1, p141 

    Stem cells are classified into embryonic stem cells and adult stem cells. An evolving alternative to conventional stem cell therapies is induced pluripotent stem cells (iPSCs), which have a multi-lineage potential comparable to conventionally acquired embryonic stem cells with the additional...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics